Tailored Physiotherapy Compared With Usual Care in Amyotrophic Lateral Sclerosis
Tests physiotherapy tailored to each person's muscle weaknesses in people with ALS.
Plain-language title generated from the registry record
Registry title: A Physiotherapy Intervention Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Key facts
- Where
- Sankt Gallen, SwitzerlandSee the site
Where in Switzerland
- ALS ClinicSankt Gallen, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Charlotte Vogt
- Trial code
- NCT07341984
- Record updated
- 15 January 2026
- Original description
This study investigates whether an individualized physiotherapy program, tailored to each patient's specific motor deficits, can better support physical function compared with usual care physiotherapy in people with ALS.Read full original descriptionShow less
Individualized Physiotherapy Addressing Patient-Specific Deficits in Amyotrophic Lateral Sclerosis Compared to Usual Care Physiotherapy: A Prospective, Pseudorandomized, Controlled, Interventional Study
This study investigates whether an individualized physiotherapy program, tailored to each patient's specific motor deficits, can better support physical function compared with usual care physiotherapy in people with ALS.
The individualized program is guided by diagnostic assessments using a robotic leg press system, which helps identify strengths and weaknesses in muscle function and movement control.
Participants will receive either individualized physiotherapy or standard physiotherapy and will be followed for 12 months. The aim of the study is to improve physiotherapy strategies for people with ALS in a safe and patient-centered manner.
Inclusion: diagnosis of clinically probable, probable laboratory-supported, or definite ALS (revised El Escorial criteria) or upper motor neuron only (OPM classification [onset, propagation, motoneuron involvement]); age ≥18 years; ability to understand study information and provide written informed consent; Willingness and ability to perform individualized exercise according to the study protocol (approximately three to five sessions of 30 minutes per week) for the duration of the intervention period; Individuals of all sexes and gender identities are eligible for inclusion.
Exclusion: concomitant life-threatening disease or impairment interfering with functional assessment; pregnancy, tracheostomy, continuous assisted ventilation, or other significant non-ALS pulmonary disease; other neurodegenerative or neuromuscular conditions that may confound assessments.